Literature DB >> 21523202

Coronary revascularization in diabetic patients: Current state of evidence.

Mukesh Singh1, Rohit Arora, Vamsi Kodumuri, Sandeep Khosla, Evyan Jawad.   

Abstract

Although diabetic patients constitute an increasing number of individuals undergoing percutaneous coronary intervention (PCI) and surgical revascularization, they experience worse outcomes than nondiabetic patients. The optimal coronary revascularization strategy in the diabetic population remains unclear in view of advancements in pharmacotherapy and technology of both PCI and surgical revascularization. Data to guide decision making are limited regarding the current choice between coronary artery bypass graft surgery and PCI using drug-eluting stents and newer antiplatelet agents in diabetic patients with multivessel coronary artery disease. The present article summarizes the current state of evidence for coronary revascularization in the diabetic population.

Entities:  

Keywords:  CABG; Coronary revascularization; Diabetes mellitus; PCI

Year:  2011        PMID： 21523202      PMCID： PMC3076161     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN： 1205-6626


  95 in total

1.  Diabetes and complications after cardiac surgery: comparison with a non-diabetic population.

Authors:  L Morricone; M Ranucci; S Denti; A Cazzaniga; G Isgrò; R Enrini; F Caviezel
Journal:  Acta Diabetol       Date:  1999-06       Impact factor: 4.280

2.  Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus.

Authors:  Carlo Briguori; Gerolama Condorelli; Flavio Airoldi; Amelia Focaccio; Davide D'Andrea; Mario Cannavale; Alireza Afzali Abarghouei; Salvatore Giordano; Fabrizio De Vivo; Bruno Ricciardelli; Antonio Colombo
Journal:  Am J Cardiol       Date:  2007-01-19       Impact factor: 2.778

3.  Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.

Authors:  Whady Hueb; Neuza Helena Lopes; Bernard J Gersh; Paulo Soares; Luiz A C Machado; Fabio B Jatene; Sergio A Oliveira; Jose A F Ramires
Journal:  Circulation       Date:  2007-03-06       Impact factor: 29.690

4.  Effectiveness of revascularization in the Emory angioplasty versus surgery trial. A randomized comparison of coronary angioplasty with bypass surgery.

Authors:  X Q Zhao; B G Brown; D K Stewart; L A Hillger; H X Barnhart; A S Kosinski; W S Weintraub; S B King
Journal:  Circulation       Date:  1996-06-01       Impact factor: 29.690

5.  Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery.

Authors:  Jeffrey L Carson; Peter M Scholz; Anita Y Chen; Eric D Peterson; Jeffrey Gold; Stephen H Schneider
Journal:  J Am Coll Cardiol       Date:  2002-08-07       Impact factor: 24.094

6.  Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery.

Authors:  L R Smith; F E Harrell; J S Rankin; R M Califf; D B Pryor; L H Muhlbaier; K L Lee; D B Mark; R H Jones; H N Oldham
Journal:  Circulation       Date:  1991-11       Impact factor: 29.690

7.  A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

Authors:  Adnan Kastrati; Julinda Mehilli; Helmut Schühlen; Josef Dirschinger; Franz Dotzer; Jurriën M ten Berg; Franz-Josef Neumann; Hildegard Bollwein; Christian Volmer; Meinrad Gawaz; Peter B Berger; Albert Schömig
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

8.  Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty.

Authors:  B Stein; W S Weintraub; S P Gebhart; C L Cohen-Bernstein; R Grosswald; H A Liberman; J S Douglas; D C Morris; S B King
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

Review 9.  Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials.

Authors:  C Grines; A Patel; F Zijlstra; W D Weaver; C Granger; R J Simes
Journal:  Am Heart J       Date:  2003-01       Impact factor: 4.749

10.  Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.

Authors:  Belgin Unal; Julia Alison Critchley; Simon Capewell
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690
View more
  10 in total

Review 1.  Revascularization Strategies for Non-ST-Elevation Myocardial Infarction.

Authors:  Bennet George; Naoki Misumida; Khaled M Ziada
Journal:  Curr Cardiol Rep       Date:  2019-04-10       Impact factor: 2.931

2.  'FREEDOM' trial: have the interventional cardiologists lost their freedom?

Authors:  Pankaj Jariwala; Sarat Chandra
Journal:  Indian Heart J       Date:  2013 Jan-Feb

3.  Cardiac risk assessment by gated single-photon emission computed tomography in asymptomatic end-stage renal disease patients at the start of dialysis.

Authors:  Jwa-Kyung Kim; Sung Gyun Kim; Hyung Jik Kim; Young Rim Song
Journal:  J Nucl Cardiol       Date:  2011-12-28       Impact factor: 5.952

4.  Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study.

Authors:  Daniel I Bromage; Tom R Godec; Mar Pujades-Rodriguez; Arturo Gonzalez-Izquierdo; S Denaxas; Harry Hemingway; Derek M Yellon
Journal:  Cardiovasc Diabetol       Date:  2019-12-09       Impact factor: 8.949

5.  The pleiotropic effects of metformin: time for prospective studies.

Authors:  Daniel I Bromage; Derek M Yellon
Journal:  Cardiovasc Diabetol       Date:  2015-08-14       Impact factor: 9.951

Review 6.  Management standards for stable coronary artery disease in India.

Authors:  Sundeep Mishra; Saumitra Ray; Jamshed J Dalal; J P S Sawhney; S Ramakrishnan; Tiny Nair; S S Iyengar; V K Bahl
Journal:  Indian Heart J       Date:  2016-12-09

Review 7.  Management Protocols of stable coronary artery disease in India: Executive summary.

Authors:  Sundeep Mishra; Saumitra Ray; Jamshed J Dalal; J P S Sawhney; S Ramakrishnan; Tiny Nair; S S Iyengar; Vinay K Bahl
Journal:  Indian Heart J       Date:  2016 Nov - Dec

8.  Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic Fatty rats.

Authors:  Nicholas E Buglak; Wulin Jiang; Edward S M Bahnson
Journal:  Redox Biol       Date:  2018-08-24       Impact factor: 11.799

9.  Bivalirudin Versus Heparin During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.

Authors:  Hiten Patel; Rana Garris; Suchit Bhutani; Priyank Shah; Upamanyu Rampal; Rahul Vasudev; Gabriel Melki; Bader Abu Ghalyoun; Hartaj Virk; Mahesh Bikkina; Fayez Shamoon
Journal:  Cardiol Res       Date:  2019-10-04

10.  Two-year safety and efficacy of Indigenous Abluminus Sirolimus Eluting Stent. Does it differ amongst diabetics? - Data from en-ABLe- REGISTRY.

Authors:  Kamal Sharma; Sameer Dani; Devang Desai; Prathap Kumar; Nirav Bhalani; Apurva Vasavada; Rutvik Trivedi
Journal:  J Cardiovasc Thorac Res       Date:  2021-05-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.